Hans H. Strøm

Concurrent palliative chemoradiation leads to survival and quality of life benefits in poor prognosis stage III non-small-cell lung cancer: a randomised trial by the Norwegian Lung Cancer Study Group

Hans H. Strøm, Roy M. Bremnes, Stein Sundstrøm et al. · British Journal of Cancer · 2013 · 65 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Poor Prognosis Patients with Inoperable Locally Advanced NSCLC and Large Tumors Benefit from Palliative Chemoradiotherapy: A Subset Analysis from a Randomized Clinical Phase III Trial

Hans H. Strøm, Roy M. Bremnes, Stein Sundstrøm et al. · Journal of Thoracic Oncology · 2014 · 29 citations · Full text

Medicine, Oncology, Radiation Oncology +17

The Lean method as a clinical pathway facilitator in patients with lung cancer

Ulf Aasebø, Hans H. Strøm, Merete Postmyr · The Clinical Respiratory Journal · 2011 · 26 citations

Management, Health Care Management, Oncology +17

How Do Elderly Poor Prognosis Patients Tolerate Palliative Concurrent Chemoradiotherapy for Locally Advanced Non–Small-Cell Lung Cancer Stage III? A Subset Analysis From a Clinical Phase III Trial

Hans H. Strøm, Roy M. Bremnes, Stein Sundstrøm et al. · Clinical Lung Cancer · 2014 · 22 citations · Full text

Medicine, Geriatric Medicine, Oncology +14

Chemotherapy and quality of life in NSCLC PS 2 patients

Nina Helbekkmo, Hans H. Strøm, Stein Sundstrøm et al. · Acta Oncologica · 2009 · 19 citations · Full text

Medicine, Oncology, Pharmacology +14